Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

INC Research names COO Jamie Macdonald as new CEO

This article was originally published in Scrip

Executive Summary

INC Research has promoted its current COO Jamie Macdonald to the role of CEO, when its current leader Jim Ogle leaves the post in January 2013. Ogle will continue as non-executive chairman of the board. New CEO Jamie Macdonald joined INC Research as COO in 2011 as part of the company’s acquisition of Kendle, where he served in this same capacity. 

You may also be interested in...



Hoops, hoopla, big ideas and diabetes

Perhaps only a man who inherited an enthusiasm for peptides could, without a trace of irony, cast diabetes drug development as the work of a pastry chef. But for David Solomon, the son of a peptide devotee, mixed metaphors and stretched comparisons are simply the spray thrown up by his unbridled enthusiasm for his chosen trade, that of basketball coach to GLP-1 receptor agonist developer Zealand Pharma.

Scrip Asia 100 league tables 2013

How Dennis Gillings took a gamble and built a $3.7bn business

"How the hell will Glaxo need you? You've only got a few people, they've got about 50,000!"

Latest Headlines
See All
UsernamePublicRestriction

Register

SC018533

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel